No Data
HUMAN HEALTH: 2025 Interim Report
Human Health's Fiscal H1 Profit Declines 16%
HUMAN HEALTH (01419.HK) reported mid-term revenue of approximately 0.316 billion Hong Kong dollars, an increase of about 7.0% year-on-year.
Gelonghui, February 26 - HUMAN HEALTH (01419.HK) announced that for the six months ending December 31, 2024, the group's interim income is approximately 315.8 million HKD, an increase of about 20.6 million HKD or 7.0% compared to the interim of the 2024 fiscal year. The profit attributable to the shareholders of the company is approximately 16.8 million HKD, a decrease of about 3.2 million HKD or 16.0% compared to the interim of the 2024 fiscal year. Excluding the fair value changes of financial assets accounted for at fair value through profit or loss and the fair value changes of investment properties, the profit attributable to the shareholders of the group is approximately 22 million HKD, compared to the 2024 fiscal year.
HUMAN HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 31 DECEMBER 2024
HUMAN HEALTH (01419.HK) held a Board of Directors meeting on February 26 to approve the interim results.
On February 14, Gelonghui reported that HUMAN HEALTH (01419.HK) announced that the Board of Directors meeting will be held on February 26, 2025 (Wednesday) at the 12th floor of Enterprise Square, 3 Changyue Road, Kowloon Bay, Hong Kong, to approve the interim results of the company and its subsidiaries for the six months ending December 31, 2024, and its release, as well as to consider the proposal for the distribution of an interim dividend (if any).
Human Health Buys 75% Stake in Dental Clinic Business
